89bio (NASDAQ:ETNB) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.69) by 30.43 percent. This is a 63.08 percent increase over losses of $(1.30) per share from the same period last year.
Market Downturn Ahead? Citi Strategist Warns Of Hit As Central Banks Unwind $800B Stimulus
Equities and other risk assets will take a hit when central banks pull away as much as $800…